From Global Private Credit to Programmable Securities: New to The Street Show #778 Premieres Tonight on Bloomberg Television
New to The Street announced Show #778 premiering on Bloomberg Television, a sponsored programming block featuring executive interviews with several public companies. ACXP's involvement is limited to a featured commercial describing Acurx as developing what could be the first new class of antibiotics in nearly 40 years, with lead drug ibezapolstat moving toward an FDA application based on planned Pathfinder and Aspire trials.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.